基本信息
浏览量:153
职业迁徙
个人简介
Whilst remaining an active academic, in 1991 he founded Oxford Asymmetry Ltd (an asymmetric synthesis company) as sole investor. He also founded Oxford Diversity Ltd (a combinatorial chemistry company). These two companies were combined to form Oxford Asymmetry International Plc in 1999 which was sold to Evotec in 2000, valued at £316m. In 2003 he founded VASTox (Value Added Screening Technology Oxford) a zebrafish screening company. It floated on AIM in 2004 and has since acquired Dainolabs (zebrafish) and Dextra (a carbohydrate chemistry company) as well as the assets of MNL Pharma.[6] VASTox then changed its name to Summit. In 2009 the zebrafish screening operation was acquired by Evotec for £0.5 Million.
研究兴趣
论文共 834 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Yu Liu, Nathan Thomas Coles, Nathalia Cajiao,Laurence John Taylor,Edward Stephen Davies, Alistair Barbour, Patrick Morgan,Kevin Butler, Ben Pointer-Gleadhill,Stephen Argent,Jonathan McMaster,Michael L. Neidig,
Chemical Science (2024)
Organic & biomolecular chemistryno. 42 (2023): 8535-8547
Laia Josa-Culleré,Sébastien R.G. Galan,Thomas J. Cogswell,Thomas R. Jackson,Morgan Jay-Smith, Laura Mola, Christopher R. Greaves,Tom S. Carter,Katrina S. Madden,Sophie Trott,Douzi Zhang,Carole J.R. Bataille,
European Journal of Medicinal Chemistry (2023): 115509-115509
Steven Westwood,Katrice Lippa, Yoshitaka Shimuzu, Beatrice Lalerle,Takeshi Saito,David Duewer,Xinhua Dai,Stephen Davies, Marina Ricci,Annarita Baldan,Brian Lang, Stefan Sarge,
PURE AND APPLIED CHEMISTRYno. 1 (2023): 1-77
引用0浏览0WOS引用
0
0
Organic & Biomolecular Chemistryno. 13 (2021): 2847-2855
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn